Avience Biomedicals Limited



Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026|SUBJECT: Outcome of Board Meeting



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *